TARDBP and amyotrophic lateral sclerosis: Accumulation of TDP-43 aggregates and loss of nuclear protein localization are hallmark features of almost all amyotrophic lateral sclerosis (ALS) and approximately 50% of frontotemporal dementia (FTD) patients [1–3].